Literature DB >> 4105091

Management of the asymptomatic carrier of the hepatitis-associated (Australia) antigen. Tentative considerations of the clinical and public-health aspects.

T C Chalmers, H J Alter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4105091     DOI: 10.1056/NEJM197109092851106

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

1.  Feasibility of routine testing for hepatitis B surface antigen in hospital employees and restriction of carriers.

Authors:  W D Leers; G M Kouroupis; A Dong
Journal:  Can Med Assoc J       Date:  1976-11-20       Impact factor: 8.262

2.  Hepatitis B: risk of infection from antigen-positive medical personnel and patients.

Authors: 
Journal:  Anesth Prog       Date:  1975-09

Review 3.  Halothane hepatitis--fact or fallacy?

Authors:  B R Simpson; L Strunin; B Walton
Journal:  Proc R Soc Med       Date:  1973-01

Review 4.  Current transfusion therapy.

Authors:  E Hinkes; R O Steffen
Journal:  Calif Med       Date:  1973-05

Review 5.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1972-06       Impact factor: 2.401

6.  Viral hepatitis related antigens in 'autoimmune' hepatic disorders.

Authors:  D Doniach; S Del Prete; D S Dane; J H Walsh
Journal:  Can Med Assoc J       Date:  1972-02-26       Impact factor: 8.262

7.  Liver function and histology in asymptomatic Chinese military personnel with hepatitis B antigenemia.

Authors:  K E Anderson; S C Sun; H S Berg; N K Chang
Journal:  Am J Dig Dis       Date:  1974-08

8.  Role of chronic hepatitis in development of thalassaemic liver disease.

Authors:  G Masera; G Jean; G Gazzola; M Novakova
Journal:  Arch Dis Child       Date:  1976-09       Impact factor: 3.791

9.  Frequency of hepatitis B antigen in blood donors.

Authors:  D M Wrobel; V Feinman; B Berris; J Sinclair
Journal:  Can Med Assoc J       Date:  1973-03-03       Impact factor: 8.262

10.  Liver disease and cell-mediated immunity in hepatitis-associated antigen (HAA) carriers.

Authors:  T D Bolin; A E Davis; A G Liddelow
Journal:  Gut       Date:  1973-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.